MyFinsight
Home
Blog
About
Contact
kymr: the balance sheet
Download
Download image
Total property and
equipment
$67,483K
Prepaid expenses and
other current assets
$22,616K
Marketable securities
(note 4)
$392,733K
Cash and cash
equivalents
$112,949K
Restricted cash
$5,788K
Other non-current
assets
$6,828K
Right-of-use assets,
operating leases
$42,947K
Property and equipment,
net (note 6)
$45,128K
Marketable securities,
non-current (note 4)
$473,055K
Total current assets
$528,298K
Less accumulated
depreciation
$22,355K
Total assets
$1,102,044K
Total liabilities and
stockholders equity
$1,102,044K
Total stockholders
equity
$946,258K
Total liabilities
$155,786K
Accumulated deficit
-$978,980K
Accumulated other
comprehensive loss
$1,501K
Additional paid-in capital
$1,923,730K
Finance lease
liabilities, net of current...
$1,804K
Operating lease
liabilities, net of current...
$68,450K
Deferred revenue, net of
current portion
$13,957K
Total current
liabilities
$71,575K
Common stock, 0.0001
par value...
$7K
Other current
liabilities
$408K
Finance lease
liabilities
$1,890K
Operating lease
liabilities
$11,853K
Deferred revenue
$23,279K
Accrued expenses (note
8)
$28,639K
Accounts payable
$5,506K
Back
Back
Balance Sheet
source: myfinsight.com
Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. (KYMR)